Literature DB >> 9621011

Modulation of viral immunoinflammatory responses with cytokine DNA administered by different routes.

S Chun1, M Daheshia, N A Kuklin, B T Rouse.   

Abstract

The efficacy of plasmid DNA encoding cytokine administered by different routes, systemic or surface exposure, was evaluated and compared for their modulating effects on subsequent lesions caused by infection with herpes simplex virus (HSV). Systemic or topical administration of both interleukin-4 (IL-4) and IL-10 DNA but not IL-2 DNA caused a long-lasting suppression of HSV-specific delayed-type hypersensitivity response. IL-4 or IL-10 DNA preadministration also modulated the expression of immunoinflammatory lesions associated with corneal infection of HSV. Suppression of ocular lesions required that the DNA be administered to the nasal mucosa or ocular surfaces and was not evident after intramuscular administration. The modulating effect of IL-10 DNA was most evident after topical ocular administration, whereas the effects of IL-4 DNA given by both routes appeared to be equal. Preexposure of IL-4 DNA, but not IL-10 DNA, resulted in a significant change in Th subset balance following HSV infection. Our results indicate that the modulating effect of IL-4 or IL-10 DNA may proceed by different mechanisms. Furthermore, our results suggest that surface administration of cytokine DNA is a convenient means of modulating immunoinflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9621011      PMCID: PMC110202     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  21 in total

1.  Role of macrophages and dendritic cells in primary cytotoxic T lymphocyte responses.

Authors:  S Nair; A M Buiting; R J Rouse; N Van Rooijen; L Huang; B T Rouse
Journal:  Int Immunol       Date:  1995-04       Impact factor: 4.823

2.  Immune induction and modulation by topical ocular administration of plasmid DNA encoding antigens and cytokines.

Authors:  M Daheshia; N Kuklin; E Manickan; S Chun; B T Rouse
Journal:  Vaccine       Date:  1998-07       Impact factor: 3.641

3.  Alterations in the antigenic structure of two major HSV-1 glycoproteins, gC and gB, influence immune regulation and susceptibility to murine herpes keratitis.

Authors:  R L Hendricks; M S Tao; J C Glorioso
Journal:  J Immunol       Date:  1989-01-01       Impact factor: 5.422

4.  Proteins specified by herpes simplex virus. V. Purification and structural proteins of the herpesvirion.

Authors:  P G Spear; B Roizman
Journal:  J Virol       Date:  1972-01       Impact factor: 5.103

5.  Predominance of Th1 cells in ocular tissues during herpetic stromal keratitis.

Authors:  M G Niemialtowski; B T Rouse
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

6.  Exacerbation of murine herpes simplex virus-mediated stromal keratitis by Th2 type T cells.

Authors:  S Jayaraman; A Heiligenhaus; A Rodriguez; S Soukiasian; M E Dorf; C S Foster
Journal:  J Immunol       Date:  1993-11-15       Impact factor: 5.422

7.  IFN-gamma and IL-2 are protective in the skin but pathologic in the corneas of HSV-1-infected mice.

Authors:  R L Hendricks; T M Tumpey; A Finnegan
Journal:  J Immunol       Date:  1992-11-01       Impact factor: 5.422

8.  Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.

Authors:  E Manickan; R J Rouse; Z Yu; W S Wire; B T Rouse
Journal:  J Immunol       Date:  1995-07-01       Impact factor: 5.422

9.  Vaccination with recombinant vaccinia viruses expressing ICP27 induces protective immunity against herpes simplex virus through CD4+ Th1+ T cells.

Authors:  E Manickan; M Francotte; N Kuklin; M Dewerchin; C Molitor; D Gheysen; M Slaoui; B T Rouse
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

10.  Human tumor necrosis factor receptor (p55) and interleukin 10 gene transfer in the mouse reduces mortality to lethal endotoxemia and also attenuates local inflammatory responses.

Authors:  M A Rogy; T Auffenberg; N J Espat; R Philip; D Remick; G K Wollenberg; E M Copeland; L L Moldawer
Journal:  J Exp Med       Date:  1995-06-01       Impact factor: 14.307

View more
  9 in total

1.  Pathogenesis of herpes simplex virus-induced ocular immunoinflammatory lesions in B-cell-deficient mice.

Authors:  S P Deshpande; M Zheng; M Daheshia; B T Rouse
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis.

Authors:  S P Deshpande; S Lee; M Zheng; B Song; D Knipe; J A Kapp; B T Rouse
Journal:  J Virol       Date:  2001-04       Impact factor: 5.103

3.  Immunomodulation by topical particle-mediated administration of cytokine plasmid DNA suppresses herpetic stromal keratitis without impairment of antiviral defense.

Authors:  Dirk Bauer; Mengji Lu; Susanne Wasmuth; Haiping Li; Yanning Yang; Michael Roggendorf; Klaus Peter Steuhl; Arnd Heiligenhaus
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-07-27       Impact factor: 3.117

4.  Modulation of immunity against herpes simplex virus infection via mucosal genetic transfer of plasmid DNA encoding chemokines.

Authors:  S K Eo; S Lee; S Chun; B T Rouse
Journal:  J Virol       Date:  2001-01       Impact factor: 5.103

5.  The dominant-negative herpes simplex virus type 1 (HSV-1) recombinant CJ83193 can serve as an effective vaccine against wild-type HSV-1 infection in mice.

Authors:  Hanka Augustinova; Daniela Hoeller; Feng Yao
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

6.  Protection against recurrent ocular herpes simplex virus type 1 disease after therapeutic vaccination of latently infected mice.

Authors:  C M Richards; R Case; T R Hirst; T J Hill; N A Williams
Journal:  J Virol       Date:  2003-06       Impact factor: 5.103

7.  Overexpression of interleukin-2 by a recombinant herpes simplex virus type 1 attenuates pathogenicity and enhances antiviral immunity.

Authors:  Homayon Ghiasi; Yanira Osorio; Guey-Chuen Perng; Anthony B Nesburn; Steven L Wechsler
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

Review 8.  Gene Therapy in the Anterior Eye Segment.

Authors:  Cynthia Amador; Ruchi Shah; Sean Ghiam; Andrei A Kramerov; Alexander V Ljubimov
Journal:  Curr Gene Ther       Date:  2022       Impact factor: 4.391

9.  Targeting herpetic keratitis by gene therapy.

Authors:  Hossein Mostafa Elbadawy; Marine Gailledrat; Carole Desseaux; Diego Ponzin; Stefano Ferrari
Journal:  J Ophthalmol       Date:  2012-12-26       Impact factor: 1.909

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.